(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed.
Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk…
Source link : https://www.medpagetoday.com/neurology/seizures/118973
Author :
Publish date : 2025-12-11 22:15:00
Copyright for syndicated content belongs to the linked Source.
